GSK plc

GSK plc

GSK.L - LONDON STOCK EXCHANGE

Industry: Pharmaceuticals

Market Cap: 55.2 B

IPO Date: May 22, 1972

Country: GB

Currency: GBP

Shares Outstanding: 4.1 B

2024 Total Dividend Income And Portfolio Update

5/7/2025

2024 also saw some changes to some of my holdings as the author shuttled several dividend income payers for higher return crypto plays. Click to read.

News

Source: SeekingAlpha

5 Reasons GSK Looks Good

5/5/2025

GSK plc's stock price has significantly outperformed the healthcare sector this year, supported by its healthy Q1 2025 numbers. Learn more about GSK stock here.

News

Source: SeekingAlpha

GSK First Quarter 2025 Earnings: EPS Beats Expectations

5/4/2025

GSK ( LON:GSK ) First Quarter 2025 Results Key Financial Results Revenue: UK£7.52b (up 2.1% from 1Q 2024). Net income...

News

Source: Yahoo

GSK (LON:GSK) Will Pay A Dividend Of £0.16

5/3/2025

The board of GSK plc ( LON:GSK ) has announced that it will pay a dividend on the 10th of July, with investors...

News

Source: Yahoo

GSK PLC (GSK) Q1 2025 Earnings Call Highlights: Strong Specialty Medicines Growth Amid Vaccine ...

5/1/2025

GSK PLC (GSK) reports a robust 17% increase in specialty medicines sales, while vaccine sales face a 6% decline, impacting overall performance.

News

Source: Yahoo

US risks recession as economy shrinks in tariff war

4/30/2025

The US risks being thrown into recession by Donald Trump’s trade war as official figures showed the economy shrank during the first three months of the year.

News

Source: Yahoo

GSK Jumps On Solid Earnings, Says It's 'Well Positioned' To Navigate Tariffs

4/30/2025

GSK stock jumped Wednesday after the British drugmaker said it's "well positioned" to respond if the U.S. levies tariffs on drug imports.

News

Source: Yahoo

GSK (LSE:GSK) Sees First Quarter Sales of £7.5 Billion and Net Income Surge

4/30/2025

GSK (LSE:GSK) reported a significant improvement in its first-quarter earnings, with sales, net income, and earnings per share all showing promising growth. This announcement coincided with a 5.14% rise in GSK's shares over the past week. Meanwhile, broader market trends have been characterized by volatility, with the major indexes seeing declines following a weak GDP report. Despite these fluctuations, GSK's positive earnings report likely bolstered investor sentiment, helping the company to...

News

Source: Yahoo

Wall Street falls while FTSE 100 regains losses after US economy shrinks

4/30/2025

The American economy contracted by 0.3% in the first three months of the year amid Donald Trump’s threats of sweeping trade tariffs.

News

Source: Yahoo

Tariff turmoil prompts cloudy forecasts from companies for the year ahead

4/30/2025

Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as they try to navigate a global trade system severely shaken by a shift in U.S. policy. Tariffs and the stark shift in policy has also shaken consumer and business confidence. The U.S. economy shrank during the first quarter of the year, its first drop in three years.

News

Source: Yahoo

GSK plc (GSK) Q1 2025 Earnings Conference Call Transcript

4/30/2025

GSK plc (NYSE:GSK) Q1 2025 Earnings Conference Call April 30, 2025 7:00 AM ETCompany ParticipantsConstantin Fest - Head of IREmma Walmsley - CEOLuke Miels -...

News

Source: SeekingAlpha

Trending tickers: Super Micro, Starbucks, Snap, GSK and Aston Martin

4/30/2025

The latest investor updates on stocks that are trending on Wednesday.

News

Source: Yahoo

GSK (GSK) Q1 Earnings Surpass Estimates

4/30/2025

Glaxo (GSK) delivered earnings and revenue surprises of 4.63% and 0.85%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

News

Source: Yahoo

Drugs giant GSK ‘well positioned’ to absorb potential US tariffs

4/30/2025

It came as the FTSE 100 giant revealed a rise in sales as weakness in its vaccine division was offset by growth in speciality medicines.

News

Source: Yahoo

GSK Sales, Profit Rise on Boost from HIV, Cancer Drugs

4/30/2025

GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand in the U.S.

News

Source: Yahoo

GSK 'well positioned' for potential tariffs after beating forecasts

4/30/2025

GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts and dual sourcing for its medicines, but offered few details. The British drugmaker reported stronger-than-expected first-quarter results and reaffirmed its 2025 outlook, sending its shares up 3.8% by 0900 GMT. They were among the top gainers on London's FTSE 100 index, which was up 0.02%.

News

Source: Yahoo

SpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEO

4/29/2025

Merck KGaA acquires SpringWorks Therapeutics, Inc. for $3.9B, boosting its pipeline with OGSIVEO & GOMEKLI. Click for more on SWTX and MKGAF stock post deal.

News

Source: SeekingAlpha

Is GSK plc (GSK) the Best Undervalued UK Stock to Buy Right Now?

4/25/2025

We recently published a list of the 11 Best Undervalued UK Stocks to Buy Right Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best undervalued UK stocks to buy right now. The UK and Europe’s Performance in Q1 2025 The global markets entered 2025 […]

News

Source: Yahoo

Stocks to watch next week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca

4/25/2025

Earnings preview of key companies reporting next week and what to look out for.

News

Source: Yahoo

Shingles Vaccine Appears to Lower Dementia Risk

4/23/2025

Mounting evidence suggests that vaccination against the varicella zoster virus—which causes chickenpox in children and triggers shingles in adults—also protects the brain. Several recent studies suggest that the vaccines reduce the risk of dementia in older adults, but key questions remain, including: How the vaccines might work to stop or delay the condition, and whether the benefit is limited to people of a certain age. The vaccines studied, Zostavax and Shingrix, both appeared to offer protection.

News

Source: Yahoo